TransMedics Group, Inc. (TMDX)

TransMedics Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,646	2,093	2,577	1,970	532	541
Market Cap Growth	-8.61%	-18.80%	30.78%	270.34%	-1.57%	37.38%
Enterprise Value	3,764	2,281	2,665	1,834	464	442
Last Close Price	106.94	62.35	78.93	61.72	19.16	19.90
PE Ratio	52.99	59.01	-	-	-	-
Forward PE	46.59	56.70	-	-	-	-
PS Ratio	6.78	4.74	10.67	21.08	17.58	21.08
PB Ratio	11.44	9.15	18.78	10.52	7.84	5.20
P/TBV Ratio	12.27	9.74	20.97	10.52	7.84	5.20
P/OCF Ratio	31.63	42.88	-	-	-	-
EV/Sales Ratio	7.08	5.17	11.03	19.62	15.34	17.25
EV/EBITDA Ratio	37.53	39.83	307.71	-	-	-
EV/EBIT Ratio	49.15	60.82	5495.72	-	-	-
Debt / Equity Ratio	1.63	2.27	3.76	0.36	0.65	0.33
Debt / EBITDA Ratio	4.85	8.19	38.35	-	-	-
Asset Turnover	0.64	0.59	0.49	0.45	0.21	0.20
Inventory Turnover	4.64	3.95	2.70	1.59	0.68	0.78
Quick Ratio	8.93	7.25	8.34	9.67	4.23	11.16
Current Ratio	9.86	8.30	9.30	10.66	5.11	12.36
Return on Equity (ROE)	28.21%	19.39%	-15.42%	-28.39%	-51.49%	-36.27%
Return on Assets (ROA)	5.80%	3.10%	0.06%	-9.54%	-17.18%	-12.82%
Return on Capital (ROIC)	6.20%	3.35%	0.07%	-10.72%	-19.70%	-14.51%
Return on Capital Employed (ROCE)	9.20%	5.00%	0.10%	-	-	-
Earnings Yield	1.97%	1.70%	-0.97%	-1.84%	-8.31%	-5.32%
FCF Yield	0.48%	-3.87%	-6.40%	-2.93%	-6.09%	-5.68%
Buyback Yield / Dilution	-11.94%	-8.30%	-10.02%	-7.02%	-11.80%	-73.91%

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q